Giulia C. Kennedy - 03 Mar 2022 Form 4/A - Amendment Insider Report for VERACYTE, INC. (VCYT)

Role
Chief Scientific & Med Officer
Signature
/s/ Jane Alley as attorney-in-fact
Issuer symbol
VCYT
Transactions as of
03 Mar 2022
Net transactions value
-$552,181
Form type
4/A - Amendment
Filing time
09 Mar 2022, 19:46:11 UTC
Date Of Original Report
07 Mar 2022
Previous filing
04 Mar 2022
Next filing
06 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCYT Common Stock Award $0 +42,412 +113% $0.000000 79,987 03 Mar 2022 Direct F1
transaction VCYT Common Stock Options Exercise $26,354 +4,407 +5.5% $5.98 84,394 04 Mar 2022 Direct F2
transaction VCYT Common Stock Sale $425,697 -17,089 -20% $24.91 67,305 04 Mar 2022 Direct F2, F3
transaction VCYT Common Stock Sale $150,189 -5,844 -8.7% $25.70 61,461 04 Mar 2022 Direct F2, F4
transaction VCYT Common Stock Sale $2,649 -100 -0.16% $26.49 61,361 04 Mar 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCYT Stock Option (right to buy) Award $0 +77,287 $0.000000 77,287 03 Mar 2022 Common Stock 77,287 $26.02 Direct F5
transaction VCYT Stock Option (right to buy) Options Exercise $0 -4,407 -100% $0.000000* 0 04 Mar 2022 Common Stock 4,407 $5.98 Direct F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units awarded on March 3, 2022 vest 25% on March 2, 2023 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.
F2 The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2021.
F3 Represents weighted average sales price. Sale prices for the transactions range from $24.40 to $25.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
F4 Represents weighted average sales price. Sale prices for the transactions range from $25.41 to $26.26. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
F5 The option becomes exercisable as to 25% of the shares on March 3, 2023, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
F6 The option is fully vested.

Remarks:

This amendment to Form 4 filed on March 7, 2022 is filed to correct the amount of securities sold on March 4, 2022 and the sale price applicable thereto as reflected in Column 4 of Table 1.